These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 12777314

  • 1. Aldosterone blockade in patients with acute myocardial infarction.
    Pitt B.
    Circulation; 2003 May 27; 107(20):2525-7. PubMed ID: 12777314
    [No Abstract] [Full Text] [Related]

  • 2. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers.
    Aaronson K.
    Health News; 2003 May 27; 9(5):4. PubMed ID: 12739453
    [No Abstract] [Full Text] [Related]

  • 3. Aldosterone blockade after myocardial infarction.
    Hackam DG.
    CMAJ; 2003 Sep 02; 169(5):444. PubMed ID: 12952808
    [No Abstract] [Full Text] [Related]

  • 4. Should the aldosterone-receptor antagonist - eplerenone - be used after acute myocardial infarction with left ventricular dysfunction?
    Doggrell S.
    Expert Opin Pharmacother; 2003 Sep 02; 4(9):1605-7. PubMed ID: 12943490
    [No Abstract] [Full Text] [Related]

  • 5. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
    Pitt B.
    J Card Fail; 2002 Dec 02; 8(6 Suppl):S491-3. PubMed ID: 12555163
    [Abstract] [Full Text] [Related]

  • 6. [Misdiagnosed emergency: heart failure symptoms after infarct. Rapid aldosterone block can safe the tired heart].
    MMW Fortschr Med; 2008 May 29; 150(22):48-9. PubMed ID: 18700263
    [No Abstract] [Full Text] [Related]

  • 7. Aldosterone blockade in patients with systolic left ventricular dysfunction.
    Pitt B.
    Circulation; 2003 Oct 14; 108(15):1790-4. PubMed ID: 14557343
    [No Abstract] [Full Text] [Related]

  • 8. Aldosterone blockade and heart failure.
    Jessup M.
    N Engl J Med; 2003 Apr 03; 348(14):1380-2. PubMed ID: 12668698
    [No Abstract] [Full Text] [Related]

  • 9. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul 07; 147(27-28):44. PubMed ID: 16041942
    [No Abstract] [Full Text] [Related]

  • 10. Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction.
    Weir RA, Tsorlalis IK, Steedman T, Dargie HJ, Fraser R, McMurray JJ, Connell JM.
    Eur J Heart Fail; 2011 Dec 07; 13(12):1305-13. PubMed ID: 21940729
    [Abstract] [Full Text] [Related]

  • 11. [Mineralocorticoid receptor antagonist spironolactone improves left ventricular remodeling in patients with congestive heart failure and acute myocardial infarction].
    Tsutamoto T.
    Nihon Yakurigaku Zasshi; 2004 Aug 07; 124(2):90-100. PubMed ID: 15277727
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE, Marwick TH, Krum H.
    Cardiovasc Revasc Med; 2006 Aug 07; 7(4):234-6. PubMed ID: 17174870
    [Abstract] [Full Text] [Related]

  • 13. Effects of spironolactone and fosinopril on the spontaneous and chronic ventricular arrhythmias in a rat model of myocardial infarction.
    Beck L, Blanc-Guillemaud V, Cherif OK, Jover B, Davy JM.
    Cardiology; 2001 Aug 07; 96(2):85-93. PubMed ID: 11740137
    [Abstract] [Full Text] [Related]

  • 14. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D, Galuppo P, Schmidt I, Ertl G, Bauersachs J.
    Cardiovasc Res; 2005 Jul 01; 67(1):97-105. PubMed ID: 15949473
    [Abstract] [Full Text] [Related]

  • 15. Eplerenone in the treatment of chronic heart failure.
    Krum H, Liew D.
    Expert Rev Cardiovasc Ther; 2004 May 01; 2(3):315-20. PubMed ID: 15151479
    [Abstract] [Full Text] [Related]

  • 16. Eplerenone in patients with left ventricular dysfunction.
    Aggarwal A.
    N Engl J Med; 2003 Jul 03; 349(1):88-9; author reply 88-9. PubMed ID: 12840098
    [No Abstract] [Full Text] [Related]

  • 17. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
    Hayashi M.
    J Cardiol; 2004 Feb 03; 43(2):88-91. PubMed ID: 15046031
    [Abstract] [Full Text] [Related]

  • 18. Eplerenone in patients with left ventricular dysfunction.
    Coca SG, Buller GK.
    N Engl J Med; 2003 Jul 03; 349(1):88-9; author reply 88-9. PubMed ID: 12846223
    [No Abstract] [Full Text] [Related]

  • 19. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T, Matsubara H.
    Nihon Rinsho; 2006 Jul 03; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract] [Full Text] [Related]

  • 20. [Aldosterone and aldosterone antagonists. Eplerenone in cardiac insufficiency after myocardial infarction].
    Heinzl S.
    Med Monatsschr Pharm; 2005 Mar 03; 28(3):76-9. PubMed ID: 15794365
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.